Retracted: CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits A β1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway
- PMID: 37416293
- PMCID: PMC10322307
- DOI: 10.1155/2023/9817614
Retracted: CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits A β1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway
Abstract
[This retracts the article DOI: 10.1155/2022/1949344.].
Copyright © 2023 Computational and Mathematical Methods in Medicine.
Retraction of
-
CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ 1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway.Comput Math Methods Med. 2022 Sep 8;2022:1949344. doi: 10.1155/2022/1949344. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Jun 28;2023:9817614. doi: 10.1155/2023/9817614. PMID: 36118839 Free PMC article. Retracted.
References
-
- Guo C., Li Q., Xiao J., et al. CX3CL1 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Aβ1-42-Induced SH-SY5Y Cell Pathological Damage through TXNIP/NLRP3 Signaling Pathway. Computational and Mathematical Methods in Medicine . 2022;2022:12. doi: 10.1155/2022/1949344.1949344 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
